09 Apr KMW advised EQT on its sale of Karo Healthcare to KKR
Our firm acted as Dutch counsel to Nasdaq-listed private equity firm EQT on its EUR 2,6 billion sale of Karo Healthcare, a leading pan-European consumer health care company, to leading global investment firm KKR. Karo operates a product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. The Netherlands serves as an important hub for Karo, housing various Dutch legal entities responsible for a substantial part of Karo’s Healthcare’s annual turnover. White & Case acted as lead counsel to EQT.